APYX logo

APYX MEDICAL CORP

APYXNASDAQ
πŸ† #3913 by market capEarnings Nov 5US Equity
$2.60β–² $0.15 (+5.92%)
Market closed Β· at close
πŸ””
Track APYX
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 5.9%
7dβ–² 8.6%
14dβ–² 2.8%
30dβ–Ό 0.6%
ytdβ–Ό 26.2%
1yβ–Ό 12.0%
🏦Market Cap
$109M
Small Cap
πŸ“ˆRevenue Growth (YoY)
9.9%
Slowing
πŸ“ŠGross Margin
33.9%
Moderate
πŸ’΅FCF Margin
-18.9%
Thin
βš–οΈP/S Ratio
1.9x
Cheap
Otter Score
60
Fair

Trading Snapshot

Day Range
$2.55 – $2.60
52-Week Range
$2.25 – $5.08
Volume (shares)
1,064
Avg Volume (shares)
β€”
Shares Outstanding
42.1M
Next Earnings
2026-11-05

Fundamentals Snapshot

Annual Revenue
$53M
Last Q Revenue
$14M
P/E Ratio
-12.6
P/S Ratio
1.9x
EPS (TTM)
$-0.20
Dividend Yield
0.00%
Dilution (1yr)
+10.3%
APYX logo

APYX MEDICAL CORP

APYX
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$53Mβ–² +9.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
36.0%β–Ό βˆ’41.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$6Mβ–Ό βˆ’65.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$9Mβ–Ό βˆ’51.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
42.2Mβ–² +10.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$8Mβ–Ό βˆ’$577K YoY
StockOtter Β· stockotter.space

About APYX MEDICAL CORP

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
60/100

Analyst Ratings

β“˜
Consensus
Buy
12 analysts
Strong Buy3
Buy8
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.